$1.13 Billion is the total value of Camber Capital Management LP's 37 reported holdings in Q4 2013. The portfolio turnover from Q3 2013 to Q4 2013 was 60.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TEVA | Buy | TEVA PHARMACEUTICAL IND LTDcall | $90,180,000 | +19.3% | 2,250,000 | +12.5% | 7.95% | +0.4% |
| TEVA | TEVA PHARMACEUTICAL IND LTDadr | $80,160,000 | +6.1% | 2,000,000 | 0.0% | 7.07% | -10.7% | |
| MYL | Sell | MYLAN INC | $75,950,000 | +4.7% | 1,750,000 | -7.9% | 6.70% | -11.9% |
| V107SC | Sell | WELLPOINT INC | $73,912,000 | +4.0% | 800,000 | -5.9% | 6.52% | -12.5% |
| HCA | Buy | HCA HOLDINGS INC | $59,637,000 | +86.0% | 1,250,000 | +66.7% | 5.26% | +56.5% |
| CNMD | Buy | CONMED CORP | $58,862,000 | +73.2% | 1,385,000 | +38.5% | 5.19% | +45.7% |
| MNKKQ | Buy | MALLINCKRODT PUB LTD CO | $52,260,000 | +58.0% | 1,000,000 | +33.3% | 4.61% | +33.0% |
| 5100PS | Buy | VOLCANO CORPORATION | $51,347,000 | +8.7% | 2,350,000 | +19.0% | 4.53% | -8.5% |
| MRK | New | MERCK & CO. INC NEW | $49,565,000 | – | 990,300 | +100.0% | 4.37% | – |
| UNH | New | UNITEDHEALTH GROUP INC | $48,945,000 | – | 650,000 | +100.0% | 4.32% | – |
| THC | New | TENET HEALTHCARE CORP | $46,332,000 | – | 1,100,000 | +100.0% | 4.09% | – |
| DGX | QUEST DIAGNOSTICS INC | $42,832,000 | -13.4% | 800,000 | 0.0% | 3.78% | -27.1% | |
| MASI | Sell | MASIMO CORP | $41,653,000 | -10.7% | 1,425,000 | -18.6% | 3.67% | -24.8% |
| HUM | HUMANA INC | $41,288,000 | +10.6% | 400,000 | 0.0% | 3.64% | -6.9% | |
| ARIA | New | ARIAD PHARMACEUTICALS INC | $35,805,000 | – | 5,250,000 | +100.0% | 3.16% | – |
| HOLX | Sell | HOLOGIC INC | $33,525,000 | -27.8% | 1,500,000 | -33.3% | 2.96% | -39.3% |
| A | AGILENT TECHNOLOGIES, INC | $28,595,000 | +11.6% | 500,000 | 0.0% | 2.52% | -6.1% | |
| EW | New | EDWARDS LIFESCIENCES CORP | $23,016,000 | – | 350,000 | +100.0% | 2.03% | – |
| CYH | New | COMMUNITY HEALTH SYS INC NEW | $19,635,000 | – | 500,000 | +100.0% | 1.73% | – |
| UAM | Buy | UNIVERSAL AMERN CORP NEW | $18,250,000 | +257.1% | 2,500,000 | +272.8% | 1.61% | +200.4% |
| NVAX | Sell | NOVAVAX INC | $17,920,000 | +20.4% | 3,500,000 | -25.7% | 1.58% | +1.3% |
| ANGO | Sell | ANGIODYNAMICS INC | $17,190,000 | -1.9% | 1,000,000 | -24.7% | 1.52% | -17.5% |
| AMRN | New | AMARIN CORP PLCspons adr new | $16,745,000 | – | 8,500,000 | +100.0% | 1.48% | – |
| ARWR | Sell | ARROWHEAD RESH CORP | $16,275,000 | +14.4% | 1,500,000 | -40.0% | 1.44% | -3.7% |
| CCRN | CROSS CTRY HEALTHCARE INC | $15,369,000 | +64.7% | 1,540,000 | 0.0% | 1.36% | +38.7% | |
| MNTA | MOMENTA PHARMACEUTICALS INC | $14,144,000 | +22.9% | 800,000 | 0.0% | 1.25% | +3.4% | |
| GNMK | GENMARK DIAGNOSTICS INC | $12,644,000 | +9.5% | 950,000 | 0.0% | 1.12% | -7.9% | |
| NXTM | New | NXSTAGE MEDICAL INC | $8,205,000 | – | 820,535 | +100.0% | 0.72% | – |
| PLX | Buy | PROTALIX BIOTHERAPEUTICS INC | $7,780,000 | -4.1% | 2,000,000 | +11.7% | 0.69% | -19.3% |
| BIOL | Buy | BIOLASE INC | $7,646,000 | +48.9% | 2,701,612 | +0.5% | 0.67% | +25.3% |
| GERN | New | GERON CORP | $7,110,000 | – | 1,500,000 | +100.0% | 0.63% | – |
| XNPT | Buy | XENOPORT INC | $5,750,000 | +25.0% | 1,000,000 | +23.5% | 0.51% | +5.2% |
| DSCI | Sell | DERMA SCIENCES INC | $5,378,000 | -54.3% | 497,000 | -47.7% | 0.47% | -61.6% |
| TRNX | New | TORNIER N V | $4,697,000 | – | 250,000 | +100.0% | 0.41% | – |
| BLUE | Buy | BLUEBIRD BIO INC | $4,341,000 | +7.3% | 206,900 | +37.9% | 0.38% | -9.7% |
| TRGT | New | TARGACEPT INC | $768,000 | – | 185,100 | +100.0% | 0.07% | – |
| ANTH | Exit | ANTHERA PHARMACEUTICALS INCwarrant | $0 | – | -400,000 | -100.0% | 0.00% | – |
| ITMN | Exit | INTERMUNE INC | $0 | – | -500,000 | -100.0% | -0.81% | – |
| MGLN | Exit | MAGELLAN HEALTH SVCS INC | $0 | – | -175,000 | -100.0% | -1.10% | – |
| T107PS | Exit | WRIGHT MED GROUP INC | $0 | – | -711,000 | -100.0% | -1.94% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -500,000 | -100.0% | -2.48% | – |
| AZN | Exit | ASTRAZENECA PLCsponsored adr | $0 | – | -500,000 | -100.0% | -2.72% | – |
| GIVN | Exit | GIVEN IMAGING | $0 | – | -1,500,000 | -100.0% | -3.02% | – |
| MAKO | Exit | MAKO SURGICAL CORP | $0 | – | -1,200,000 | -100.0% | -3.71% | – |
| CAH | Exit | CARDINAL HEALTH INC | $0 | – | -750,000 | -100.0% | -4.10% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEVA PHARMACEUTICALS INDS LTD | 34 | Q3 2023 | 9.7% |
| BROOKDALE SR LIVING INC | 32 | Q3 2023 | 5.0% |
| PERRIGO CO PLC | 29 | Q3 2023 | 7.1% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 8.5% |
| NEKTAR THERAPEUTICS | 28 | Q1 2022 | 9.8% |
| UNIVERSAL HLTH SVCS INC | 25 | Q3 2023 | 9.9% |
| MYRIAD GENETICS INC | 24 | Q3 2023 | 5.0% |
| SAREPTA THERAPEUTICS INC | 23 | Q3 2023 | 6.0% |
| MYLAN NV | 21 | Q3 2020 | 10.1% |
| AMAG PHARMACEUTICALS INC | 21 | Q3 2020 | 4.0% |
View Camber Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC | February 02, 2023 | ? | ? |
| Solid Biosciences Inc. | December 12, 2022 | ? | ? |
| AVROBIO, Inc. | February 14, 2022 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 14, 2022 | ? | ? |
| AMAG PHARMACEUTICALS, INC. | February 16, 2021 | ? | ? |
| Atara Biotherapeutics, Inc. | February 16, 2021 | ? | ? |
| Change Healthcare Inc. | February 16, 2021 | ? | ? |
| GLYCOMIMETICS INC | February 16, 2021 | ? | ? |
| Clovis Oncology, Inc. | February 14, 2020 | ? | ? |
| Cyclerion Therapeutics, Inc. | February 14, 2020 | ? | ? |
View Camber Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-10-30 |
| 13F-HR | 2023-08-14 |
View Camber Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.